PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 29507054-7 2018 Notably, we found that MITF expression correlates with CDK2 upregulation in patients; thus, dinaciclib would warrant consideration for treatment of patients unresponsive to BRAF-MEK and/or Hsp90 inhibitors and/or harboring MITF amplification/overexpression. dinaciclib 92-102 B-Raf proto-oncogene, serine/threonine kinase Homo sapiens 173-177 33030957-4 2021 Inhibition of MEK/ERK by cobimetinib or CDK inhibitor dinaciclib was shown to attenuate mutant BRAF-induced PD-L1 coincident with reduced c-JUN and YAP expression whose combined knockdown reduced PD-L1. dinaciclib 54-64 B-Raf proto-oncogene, serine/threonine kinase Homo sapiens 95-99 31744894-5 2020 Contrary to dinaciclib, the inhibitors of BRAF / MEK / CDK4/6 induced apoptosis dominantly through a BAX-dependent mechanism. dinaciclib 12-22 B-Raf proto-oncogene, serine/threonine kinase Homo sapiens 42-46